Nicola Amodio
Nicola Amodio
Verifierad e-postadress på
Citeras av
Citeras av
Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence
MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ...
Clinical cancer research 18 (22), 6260-6270, 2012
miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease
M Rossi, MR Pitari, N Amodio, MT Di Martino, F Conforti, E Leone, C Botta, ...
Journal of cellular physiology 228 (7), 1506-1515, 2013
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ...
Cell death & disease 3 (11), e436-e436, 2012
Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth
E Leone, E Morelli, MT Di Martino, N Amodio, U Foresta, A Gullà, M Rossi, ...
Clinical Cancer Research 19 (8), 2096-2106, 2013
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
N Amodio, M Leotta, D Bellizzi, MT Di Martino, P D'Aquila, M Lionetti, ...
Oncotarget 3 (10), 1246, 2012
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma
MT Di Martino, A Gullà, MEG Cantafio, M Lionetti, E Leone, N Amodio, ...
Oncotarget 4 (2), 242, 2013
Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas
N Amodio, M Scrima, L Palaia, AN Salman, A Quintiero, R Franco, G Botti, ...
The American journal of pathology 177 (5), 2622-2634, 2010
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma
S Blotta, J Jakubikova, T Calimeri, AM Roccaro, N Amodio, AK Azab, ...
Blood, The Journal of the American Society of Hematology 120 (25), 5002-5013, 2012
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells
HM Bond, M Mesuraca, E Carbone, P Bonelli, V Agosti, N Amodio, ...
Blood 103 (6), 2062-2070, 2004
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
N Amodio, D Bellizzi, M Leotta, L Raimondi, L Biamonte, P D’Aquila, ...
Cell Cycle 12 (23), 3650-3662, 2013
Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injury
T Angelone, E Filice, T Pasqua, N Amodio, M Galluccio, G Montesanti, ...
Cellular and molecular life sciences 70 (3), 495-509, 2013
Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation
L Raimondi, A De Luca, N Amodio, M Manno, S Raccosta, S Taverna, ...
Oncotarget 6 (15), 13772, 2015
Promises and challenges of MicroRNA-based treatment of multiple myeloma
P Tagliaferri, M Rossi, M T Di Martino, N Amodio, E Leone, A Gulla, A Neri, ...
Current cancer drug targets 12 (7), 838-846, 2012
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies
N Amodio, M Rossi, L Raimondi, MR Pitari, C Botta, P Tagliaferri, ...
Oncotarget 6 (15), 12837, 2015
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity
L Raimondi, N Amodio, MT Di Martino, E Altomare, M Leotta, ...
Oncotarget 5 (10), 3039, 2014
A p53‐dependent tumor suppressor network is induced by selective miR‐125a‐5p inhibition in multiple myeloma cells
M Leotta, L Biamonte, L Raimondi, D Ronchetti, MT Di Martino, C Botta, ...
Journal of cellular physiology 229 (12), 2106-2116, 2014
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells
MT Di Martino, A Gullà, MEG Cantafio, E Altomare, N Amodio, E Leone, ...
PloS one 9 (2), e89659, 2014
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
E Morelli, E Leone, MEG Cantafio, MT Di Martino, N Amodio, L Biamonte, ...
Leukemia 29 (11), 2173-2183, 2015
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma
N Amodio, MA Stamato, AM Gullà, E Morelli, E Romeo, L Raimondi, ...
Molecular cancer therapeutics 15 (6), 1364-1375, 2016
Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma
N Amodio, MT Di Martino, A Neri, P Tagliaferri, P Tassone
Expert opinion on biological therapy 13 (sup1), S125-S137, 2013
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20